News | October 28, 2024
Strides Pharma Science reports Q2 FY25 consolidated PAT at Rs. 93.23 Cr
Strides Pharma Science has reported total income of Rs. 1,229.52 crores during the period ended September 30, 2024
Strides Pharma Science has reported total income of Rs. 1,229.52 crores during the period ended September 30, 2024
He has more than 25 years of experience in manufacturing across various industries including petrochemicals, engineering polymers, agrochemicals, organic, and inorganic intermediates
ActivShield technology is a portable, novel sterilization modality that does not require conventional infrastructure
Silica is a proven and highly effective anti-caking agent that has been used for decades
Product basket comprises 2,047 medicines and 300 surgical devices covering all major therapeutic groups
This partnership will enable healthcare organizations to provide best-in-class patient/consumer experiences
Diltiazem Hydrochloride Extended-Release Capsules USP are indicated for the treatment of hypertension
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals
Granules now has a total of 67 ANDA approvals from the USFDA
Prednisolone Acetate Ophthalmic Suspension is the first generic version of Pred Forte
Subscribe To Our Newsletter & Stay Updated
